Logo image of CX

CEMEX SAB-SPONS ADR PART CER (CX) Stock Fundamental Analysis

NYSE:CX - New York Stock Exchange, Inc. - US1512908898 - ADR - Currency: USD

7.39  -0.02 (-0.27%)

After market: 7.39 0 (0%)

Fundamental Rating

4

Overall CX gets a fundamental rating of 4 out of 10. We evaluated CX against 13 industry peers in the Construction Materials industry. CX has a medium profitability rating, but doesn't score so well on its financial health evaluation. CX may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CX was profitable.
In the past year CX had a positive cash flow from operations.
CX had positive earnings in 4 of the past 5 years.
CX had a positive operating cash flow in each of the past 5 years.
CX Yearly Net Income VS EBIT VS OCF VS FCFCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

CX has a Return On Assets of 5.98%. This is in the lower half of the industry: CX underperforms 61.54% of its industry peers.
CX has a Return On Equity of 12.93%. This is comparable to the rest of the industry: CX outperforms 46.15% of its industry peers.
CX has a Return On Invested Capital (7.56%) which is comparable to the rest of the industry.
CX had an Average Return On Invested Capital over the past 3 years of 6.81%. This is below the industry average of 10.74%.
The last Return On Invested Capital (7.56%) for CX is above the 3 year average (6.81%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.98%
ROE 12.93%
ROIC 7.56%
ROA(3y)2.44%
ROA(5y)0.96%
ROE(3y)5.81%
ROE(5y)1.39%
ROIC(3y)6.81%
ROIC(5y)6.3%
CX Yearly ROA, ROE, ROICCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

With a Profit Margin value of 8.43%, CX is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
CX's Profit Margin has improved in the last couple of years.
CX has a worse Operating Margin (10.41%) than 69.23% of its industry peers.
CX's Operating Margin has improved in the last couple of years.
CX has a better Gross Margin (33.11%) than 76.92% of its industry peers.
CX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.41%
PM (TTM) 8.43%
GM 33.11%
OM growth 3Y-1.91%
OM growth 5Y2.21%
PM growth 3Y3.44%
PM growth 5Y39.71%
GM growth 3Y1.36%
GM growth 5Y0.48%
CX Yearly Profit, Operating, Gross MarginsCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CX is destroying value.
CX has a better debt/assets ratio than last year.
CX Yearly Shares OutstandingCX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
CX Yearly Total Debt VS Total AssetsCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 1.63, we must say that CX is in the distress zone and has some risk of bankruptcy.
CX's Altman-Z score of 1.63 is on the low side compared to the rest of the industry. CX is outperformed by 61.54% of its industry peers.
CX has a debt to FCF ratio of 24.00. This is a negative value and a sign of low solvency as CX would need 24.00 years to pay back of all of its debts.
With a Debt to FCF ratio value of 24.00, CX perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
A Debt/Equity ratio of 0.45 indicates that CX is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.45, CX is doing good in the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 24
Altman-Z 1.63
ROIC/WACC0.54
WACC13.91%
CX Yearly LT Debt VS Equity VS FCFCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

CX has a Current Ratio of 0.85. This is a bad value and indicates that CX is not financially healthy enough and could expect problems in meeting its short term obligations.
CX's Current ratio of 0.85 is on the low side compared to the rest of the industry. CX is outperformed by 76.92% of its industry peers.
A Quick Ratio of 0.60 indicates that CX may have some problems paying its short term obligations.
CX's Quick ratio of 0.60 is on the low side compared to the rest of the industry. CX is outperformed by 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.6
CX Yearly Current Assets VS Current LiabilitesCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

The earnings per share for CX have decreased strongly by -81.56% in the last year.
CX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 76.58% yearly.
CX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.78%.
Measured over the past years, CX shows a small growth in Revenue. The Revenue has been growing by 4.29% on average per year.
EPS 1Y (TTM)-81.56%
EPS 3Y-35.5%
EPS 5Y76.58%
EPS Q2Q%-94.12%
Revenue 1Y (TTM)13.78%
Revenue growth 3Y4.05%
Revenue growth 5Y4.29%
Sales Q2Q%-11.8%

3.2 Future

Based on estimates for the next years, CX will show a very negative growth in Earnings Per Share. The EPS will decrease by -18.89% on average per year.
The Revenue is expected to grow by 4.14% on average over the next years.
EPS Next Y-64.42%
EPS Next 2Y-26.95%
EPS Next 3Y-18.89%
EPS Next 5YN/A
Revenue Next Year-4.17%
Revenue Next 2Y-0.52%
Revenue Next 3Y1.87%
Revenue Next 5Y4.14%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CX Yearly Revenue VS EstimatesCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50B 100B 150B 200B 250B
CX Yearly EPS VS EstimatesCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 20 -20 -40 -60

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.46, the valuation of CX can be described as very cheap.
100.00% of the companies in the same industry are more expensive than CX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CX to the average of the S&P500 Index (27.41), we can say CX is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 2.39, the valuation of CX can be described as very cheap.
100.00% of the companies in the same industry are more expensive than CX, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.19, CX is valued rather cheaply.
Industry RankSector Rank
PE 7.46
Fwd PE 2.39
CX Price Earnings VS Forward Price EarningsCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CX is valued cheaper than 100.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CX indicates a somewhat cheap valuation: CX is cheaper than 69.23% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 38.05
EV/EBITDA 4.8
CX Per share dataCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

CX's earnings are expected to decrease with -18.89% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2Y-26.95%
EPS Next 3Y-18.89%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 34.26%, CX is a good candidate for dividend investing.
CX's Dividend Yield is rather good when compared to the industry average which is at 5.05. CX pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, CX pays a better dividend.
Industry RankSector Rank
Dividend Yield 34.26%

5.2 History

CX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CX Yearly Dividends per shareCX Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

7.13% of the earnings are spent on dividend by CX. This is a low number and sustainable payout ratio.
DP7.13%
EPS Next 2Y-26.95%
EPS Next 3Y-18.89%
CX Yearly Income VS Free CF VS DividendCX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B
CX Dividend Payout.CX Dividend Payout, showing the Payout Ratio.CX Dividend Payout.PayoutRetained Earnings

CEMEX SAB-SPONS ADR PART CER

NYSE:CX (7/11/2025, 8:04:00 PM)

After market: 7.39 0 (0%)

7.39

-0.02 (-0.27%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)04-28 2025-04-28/bmo
Earnings (Next)07-24 2025-07-24
Inst Owners18.83%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.72B
Analysts81.33
Price Target7.14 (-3.38%)
Short Float %1.98%
Short Ratio2.08
Dividend
Industry RankSector Rank
Dividend Yield 34.26%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP7.13%
Div Incr Years0
Div Non Decr Years0
Ex-Date06-17 2025-06-17 (0.02238)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-45.63%
Min EPS beat(2)-88.35%
Max EPS beat(2)-2.91%
EPS beat(4)0
Avg EPS beat(4)-44.5%
Min EPS beat(4)-88.35%
Max EPS beat(4)-2.91%
EPS beat(8)1
Avg EPS beat(8)139.52%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.33%
Min Revenue beat(2)-4.86%
Max Revenue beat(2)-1.8%
Revenue beat(4)0
Avg Revenue beat(4)-5.37%
Min Revenue beat(4)-8.32%
Max Revenue beat(4)-1.8%
Revenue beat(8)1
Avg Revenue beat(8)-3.4%
Revenue beat(12)2
Avg Revenue beat(12)3.73%
Revenue beat(16)2
Avg Revenue beat(16)-4.05%
PT rev (1m)0.36%
PT rev (3m)20.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.83%
Valuation
Industry RankSector Rank
PE 7.46
Fwd PE 2.39
P/S 0.54
P/FCF 38.05
P/OCF 6
P/B 0.83
P/tB 3.09
EV/EBITDA 4.8
EPS(TTM)0.99
EY13.4%
EPS(NY)3.09
Fwd EY41.81%
FCF(TTM)0.19
FCFY2.63%
OCF(TTM)1.23
OCFY16.65%
SpS13.68
BVpS8.92
TBVpS2.4
PEG (NY)N/A
PEG (5Y)0.1
Profitability
Industry RankSector Rank
ROA 5.98%
ROE 12.93%
ROCE 9.57%
ROIC 7.56%
ROICexc 8.08%
ROICexgc 15.19%
OM 10.41%
PM (TTM) 8.43%
GM 33.11%
FCFM 1.42%
ROA(3y)2.44%
ROA(5y)0.96%
ROE(3y)5.81%
ROE(5y)1.39%
ROIC(3y)6.81%
ROIC(5y)6.3%
ROICexc(3y)7.18%
ROICexc(5y)6.61%
ROICexgc(3y)13.44%
ROICexgc(5y)12.5%
ROCE(3y)8.62%
ROCE(5y)7.97%
ROICexcg growth 3Y3.59%
ROICexcg growth 5Y8.98%
ROICexc growth 3Y3.55%
ROICexc growth 5Y10.09%
OM growth 3Y-1.91%
OM growth 5Y2.21%
PM growth 3Y3.44%
PM growth 5Y39.71%
GM growth 3Y1.36%
GM growth 5Y0.48%
F-Score7
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 24
Debt/EBITDA 1.77
Cap/Depr 121.34%
Cap/Sales 7.58%
Interest Coverage 250
Cash Conversion 54%
Profit Quality 16.85%
Current Ratio 0.85
Quick Ratio 0.6
Altman-Z 1.63
F-Score7
WACC13.91%
ROIC/WACC0.54
Cap/Depr(3y)98.23%
Cap/Depr(5y)87.02%
Cap/Sales(3y)7.21%
Cap/Sales(5y)6.61%
Profit Quality(3y)217.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.56%
EPS 3Y-35.5%
EPS 5Y76.58%
EPS Q2Q%-94.12%
EPS Next Y-64.42%
EPS Next 2Y-26.95%
EPS Next 3Y-18.89%
EPS Next 5YN/A
Revenue 1Y (TTM)13.78%
Revenue growth 3Y4.05%
Revenue growth 5Y4.29%
Sales Q2Q%-11.8%
Revenue Next Year-4.17%
Revenue Next 2Y-0.52%
Revenue Next 3Y1.87%
Revenue Next 5Y4.14%
EBIT growth 1Y12.16%
EBIT growth 3Y2.07%
EBIT growth 5Y6.6%
EBIT Next Year58.46%
EBIT Next 3Y19.8%
EBIT Next 5YN/A
FCF growth 1Y-55.57%
FCF growth 3Y-11.58%
FCF growth 5Y-3.16%
OCF growth 1Y-7.02%
OCF growth 3Y0.91%
OCF growth 5Y6.96%